apparently 1:1 entitlement issue to retail shareholders at $1-25. Should ease some of the pain, but not as much as this raising has caused.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025